Volume 28, Number 8—August 2022
Dispatch
Spiroplasma ixodetis Infections in Immunocompetent and Immunosuppressed Patients after Tick Exposure, Sweden
Table
Analysis | Reference value | Case-patient 1, immunocompetent† |
Case-patient 2, immunosuppressed‡ |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
D0 | D1 | D2 | D16 | D0 | D2 | D4 | D25 | |||
Clinical chemistry | ||||||||||
Blood | ||||||||||
Hemoglobin, g/L | 134–170 | 143 | 162 | NT | 145 | 114 | 118 | 110 | 108 | |
Leukocytes, × 109 cells/L | 3.5–8.8 | 4.2 | 3.0 | NT | 6.4 | 6.1 | 6.4 | 8.8 | 6.4 | |
Lymphocytes, × 109 cells/L | 1.1–3.5 | NT | NT | NT | 1.9 | 0.3 | NT | 0.6 | NT | |
Neutrophils, × 109 cells/L | 1.6–5.9 | NT | NT | NT | 3.7 | 4.9 | NT | 7.7 | NT | |
Platelet count, × 109/L | 140–350 | 150 | 118 | NT | 287 | 47 | 43 | 41 | 159 | |
Plasma | ||||||||||
ALT, μkat/L | <1.1 | 1.6 | 2.1 | NT | 0.85 | 3.82 | 8.18 | 13.34 | 0.48 | |
Creatinine, μmol/L | 45–90 | 66 | 73 | NT | 72 | 75 | 90 | 149 | 71 | |
CRP, mg/L |
<5 |
59 |
59 |
38 |
<1 |
197 |
158 |
164 |
<3 |
|
Vital signs | ||||||||||
O2 saturation, % | 95‒100 | 95 | 95 | 97 | 95 | 97 | 97 | NT | ||
Respiratory rate, breathes/min | 12‒16 | 20 | 18 | 20 | 20 | 24 | 20 | NT | ||
Blood pressure, mm Hg | 90/60‒120/80 | 108/50 | 94/69 | 114/56 | 117/72 | 119/66 | 120/74 | NT | ||
Heart rate, beats/min | 60‒100 | 66 | 90 | 79 | 73 | 74 | 94 | NT | ||
Temperature, °C |
37 |
38.6 |
37.4 |
36.2 |
37.1 |
39.9 |
36.4 |
NT |
||
Immunology/microbiology | ||||||||||
Serum | ||||||||||
IgG1, g/L | 4.0–10 | NT | NT | NT | 7.0 | NT | NT | NT | NT | |
IgG2, g/L | 1.7–7.9 | NT | NT | NT | 3.4 | NT | NT | NT | NT | |
IgG3, g/L | 0.1–0.85 | NT | NT | NT | 0.48 | NT | NT | NT | NT | |
IgG4, g/L | 0.03–2 | NT | NT | NT | 0.15 | NT | NT | NT | NT | |
IgA, g/L | 0.9–4.5 | NT | NT | NT | 3.7 | NT | 2.4 | NT | NT | |
IgG, g/L | 6.7–15 | NT | NT | NT | 12 | NT | 10.6 | NT | NT | |
IgM, g/L |
0.3–2.1 |
NT |
NT |
NT |
2.7 |
NT |
0.80 |
NT |
NT |
|
Blood culture | NR | ‒ | NT | NT | NT | ‒ | NT | NT | NT | |
Urine culture |
NR |
‒ |
NT |
NT |
NT |
‒ |
NT |
NT |
NT |
|
COVID-19 PCR/rapid test | NR | ‒ | NT | NT | NT | ‒ | NT | NT | NT |
*Day 0 indicates day of admission. ALT, alanine aminotransferase; COVID-19, coronavirus disease; CRP, C-reactive protein; D, day; NT, not tested; NR, not relevant; ‒, negative. †Case-patient 1 had negative PCR results for Anaplasma spp. and Neoerlichia spp. at admission to the emergency department. ‡Case-patient 2 had negative PCR results in serum for Anaplasma spp. and Neoerlichia spp. at admission, as well as negative IgG results for Anaplasma spp. Results were positive in serum for IgG against Borrelia burgdorferi and tick borne encephalitis virus, which were compatible with past infection. Molecular testing (DNA) for Epstein-Barr virus, cytomegalovirus, adenovirus, and parvovirus B19 showed negative results. Test results were negative for antinuclear antibodies and antineutrophil cytoplasmic antibodies, and urine sediment test result was unremarkable.
1Current affiliation: Sorbonne University, Paris, France.
2These authors contributed equally to this article.
3These senior authors contributed equally to this article.